Key result
Acute promyelocytic leukemia was associated with a higher incidence of hypertriglyceridemia at diagnosis compared to non-APL acute myeloid leukemia.
Why the study?
The study was conducted to investigate lipid profiles and kinetics in patients with acute promyelocytic leukemia.
Is acute promyelocytic leukemia associated with a higher incidence of hypertriglyceridemia compared to non-APL acute myeloid leukemia?
Observational (n=603)
No
Is acute promyelocytic leukemia associated with a higher incidence of hypertriglyceridemia compared to non-APL acute myeloid leukemia?
Answers are grounded in this paper and cite their sources.
Newly diagnosed acute promyelocytic leukemia is associated with a significantly higher incidence of hypertriglyceridemia compared to non-APL acute myeloid leukemia, which further increases during induction therapy but does not negatively impact survival.
The primary aim of the present retrospective study was to investigate lipid profiles and kinetics in acute promyelocytic leukemia (APL) patients. We analyzed 402 newly diagnosed APL patients and 201 non-APL patients with acute myeloid leukemia (as control). Incidence of hypertriglyceridemia in APL patients and non-APL patients was 55.82% and 28.4% ( p = 0.0003). The initial levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were higher in APL patients than in control (all p < 0.0001). In APL patients, triglyceride levels were significantly increased during induction treatment with all-trans retinoic acid and arsenic. Multivariable analysis showed that age, being overweight (body mass index ≥25) and APL were independent risk factors for hypertriglyceridemia in all patients before treatment. High triglyceride levels were not significantly associated with disease-free survival or overall survival in the APL patients. In summary, in the current study triglyceride levels were significantly elevated in APL patients before treatment, and they increased during induction treatment, but there were no significant corresponding effects on survival.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2020) conducted an observational in Acute Promyelocytic Leukemia (n=603). Acute promyelocytic leukemia vs. Non-APL acute myeloid leukemia was evaluated on Incidence of hypertriglyceridemia before treatment (OR 3.558, 95% CI 2.312-5.477, p=<0.001). Acute promyelocytic leukemia was associated with a higher incidence of hypertriglyceridemia at diagnosis compared to non-APL acute myeloid leukemia.
Synapse has enriched 10 related papers. Consider them for comparative context: